Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Propper

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Progress in Clinical and Biological Research|January 1, 1982
Neocytes and neocyte-gerocyte exchangeR D Propper
American Journal of Clinical Pathology|July 1, 1979
Microcytosis associated with sickle cell anemiaB E Glader, R D Propper, G R Buchanan
Blood|January 1, 1980
New approaches to the transfusion management of thalassemiaR D Propper, L N Button, D G Nathan
The New England Journal of Medicine|June 24, 1976
Reassessment of the use of desferrioxamine B in iron overloadR D Propper, S B Shurin, D G Nathan
Endocrinology, Diabetes & Metabolism Case Reports|April 1, 2014
A case of insulin and ACTH co-secretion by a neuroendocrine tumourS Solomou, R Khan, D Propper, et al.
British Journal of Cancer|February 7, 2008
A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study)J Stebbing, M Harrison, R Glynne-Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinomaD Propper, I Davidenko, J Bridgewater, et al.
Blood|June 1, 1982
Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinosideH J Weinstein, T W Griffin, J Feeney, et al.
British Journal of Cancer|July 17, 2003
Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxaneH Anderson, J T Yap, P Wells, et al.
The American Journal of Medicine|December 1, 1977
Treatment of iron overload in adults with continuous parenteral desferrioxamineB Cooper, H F Bunn, R D Propper, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Progress in Clinical and Biological Research|January 1, 1982
Neocytes and neocyte-gerocyte exchangeR D Propper
American Journal of Clinical Pathology|July 1, 1979
Microcytosis associated with sickle cell anemiaB E Glader, R D Propper, G R Buchanan
Blood|January 1, 1980
New approaches to the transfusion management of thalassemiaR D Propper, L N Button, D G Nathan
The New England Journal of Medicine|June 24, 1976
Reassessment of the use of desferrioxamine B in iron overloadR D Propper, S B Shurin, D G Nathan
Endocrinology, Diabetes & Metabolism Case Reports|April 1, 2014
A case of insulin and ACTH co-secretion by a neuroendocrine tumourS Solomou, R Khan, D Propper, et al.
British Journal of Cancer|February 7, 2008
A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study)J Stebbing, M Harrison, R Glynne-Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinomaD Propper, I Davidenko, J Bridgewater, et al.
Blood|June 1, 1982
Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinosideH J Weinstein, T W Griffin, J Feeney, et al.
British Journal of Cancer|July 17, 2003
Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxaneH Anderson, J T Yap, P Wells, et al.
The American Journal of Medicine|December 1, 1977
Treatment of iron overload in adults with continuous parenteral desferrioxamineB Cooper, H F Bunn, R D Propper, et al.
Pageof 2